Senores Pharmaceuticals Share Price Falls 6.46 Percent After Q1 Results

Senores Pharmaceuticals Share Price Rs 1,320.80, down 6.46 percent. Q1 PAT Rs 30.45 cr, up 43.77 percent year on year. Revenue Rs 183.02 cr, up 24.69 percent year on year.

Updated: 28 Jul 2026 • 12:18 pm

Posted by:

Senores Pharmaceuticals Share Price Falls 6.46 Percent After Q1 Results

Senores Pharmaceuticals Share Price fell 6.46 percent in trade as investors reacted to the company's June quarter FY27 results. The stock was quoting at Rs 1,320.80, down Rs 91.20 or 6.46 percent, against a previous close of Rs 1,412.00.

Senores Pharmaceuticals posted healthy profit and revenue growth for the June quarter, though both metrics declined on a sequential basis from the March quarter, with net profit margin easing to 17.05 percent from 18.04 percent in the preceding quarter.

Click Here – Get Free Investment Predictions

Table of Contents

Senores Pharmaceuticals Share Price Today: Key Trading Levels

Senores Pharmaceuticals touched an intraday high of Rs 1,414.80 and an intraday low of Rs 1,287.90 during the session, opening at Rs 1,408.30 against the previous close of Rs 1,412.00.

Metric	Value
Company	Senores Pharmaceuticals
CMP	Rs 1,320.80
Change	Rs -91.20 (-6.46 percent)
Open	Rs 1,408.30
Intraday High	Rs 1,414.80
Intraday Low	Rs 1,287.90
Previous Close	Rs 1,412.00

Check Live Stock Screener for More Pharmaceutical Sector Picks

Senores Pharmaceuticals Q1 FY27 Results: Key Numbers

Senores Pharmaceuticals reported a net profit of Rs 30.45 crore for the June quarter of FY27, up 43.77 percent year on year, compared to Rs 21.18 crore in the same quarter last year. Revenue came in at Rs 183.02 crore, up 24.69 percent year on year, against Rs 146.78 crore a year earlier.

The specialty pharmaceutical company's year on year growth remains robust even as the sequential moderation suggests some normalisation after a particularly strong March quarter performance.

Quarterly comparisons of this kind, measured against the same period a year earlier, help smooth out seasonal effects that can otherwise distort a single quarter's numbers, and remain the standard yardstick analysts use when assessing Senores Pharmaceuticals's underlying growth trajectory. Reading the headline percentage change alongside the absolute rupee figures gives a fuller picture than either number on its own.

Senores Pharmaceuticals Share Price Falls Despite YoY Growth

The stock's sharp decline appears to reflect the sequential moderation in both revenue and profit from the March quarter's stronger base, even though year on year growth trends remain healthy for the specialty pharmaceutical maker.

Senores Pharmaceuticals Share Price Outlook After Q1 Results

Senores Pharmaceuticals Share Price reaction reflects how the market is weighing the quarter's numbers against expectations. Investors tracking Senores Pharmaceuticals should watch the stock's trend over the next few sessions, along with any management commentary from the post-results earnings call, before drawing firm conclusions about the medium-term outlook.

Quarterly result days often bring above-average trading volumes as both retail and institutional investors reposition around the fresh numbers. For Senores Pharmaceuticals Share Price specifically, the next few sessions will show whether today's move holds, extends, or reverses once the broader market has had time to fully digest the details in the results filing and any accompanying investor presentation.

Download the Univest iOS App or Univest Android App to track Senores Pharmaceuticals share price movements live and get quarterly result alerts.

Conclusion

Senores Pharmaceuticals Share Price fell 6.46 percent to Rs 1,320.80 after the company posted a Q1 FY27 net profit of Rs 30.45 crore, up 43.77 percent year on year. Investors evaluating Senores Pharmaceuticals should review the full results and management commentary and consult a SEBI-registered investment advisor before making any investment decision.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs

Why did Senores Pharmaceuticals Share Price move today?

Ans. Senores Pharmaceuticals Share Price fell 6.46 percent to Rs 1,320.80 after the company reported its Q1 FY27 results, with net profit of Rs 30.45 crore, up 43.77 percent year on year.

What was Senores Pharmaceuticals's Q1 FY27 net profit?

Ans. Senores Pharmaceuticals reported a net profit of Rs 30.45 crore for the June quarter of FY27, up 43.77 percent year on year, compared to Rs 21.18 crore a year earlier.

What was the intraday range for Senores Pharmaceuticals Share Price today?

Ans. Senores Pharmaceuticals Share Price touched an intraday high of Rs 1,414.80 and an intraday low of Rs 1,287.90 during the session.

How did Senores Pharmaceuticals's revenue perform in Q1 FY27?

Ans. Senores Pharmaceuticals's revenue came in at Rs 183.02 crore in Q1 FY27, up 24.69 percent year on year, compared to Rs 146.78 crore in the same quarter last year.

Did Senores Pharmaceuticals' results improve compared to the previous quarter?

Ans. Senores Pharmaceuticals' Q1 FY27 revenue and net profit both grew year on year, but declined slightly on a sequential basis from the stronger March 2026 quarter.

Should investors buy Senores Pharmaceuticals Share Price after the Q1 results?

Ans. Investors should evaluate Senores Pharmaceuticals's full quarterly performance, management commentary, and valuation, and consult a SEBI-registered investment advisor before making any buy, hold, or sell decisions.